デフォルト表紙
市場調査レポート
商品コード
1124834

ゲノム編集技術の世界市場:2022年~2032年

Genome Editing Technologies Market Report 2022-2032

出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 416 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=204.08円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

ゲノム編集技術の世界市場:2022年~2032年
出版日: 2022年08月02日
発行: Visiongain Reports Ltd.
ページ情報: 英文 416 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のゲノム編集技術の市場規模は、2022年に推定42億2,548万米ドルと評価され、2032年までに185億7,041万米ドルに達すると予測されています。がんは、生活の質に大きな影響を及ぼす世界的な健康問題の1つです。ゲノム編集技術は、シンプルな設計、迅速な操作、低コスト、堅牢な拡張性などの利点を備え、がんの基礎研究や診断に新たな機会を提供します。

当レポートでは、世界のゲノム編集技術市場について調査分析し、市場概要、COVID-19の影響、収益予測、競合情勢、主要企業などについて、最新の情報を提供しています。

目次

第1章 レポートの概要

第2章 エグゼクティブサマリー

第3章 重要考察

第4章 市場概要

  • 主な調査結果
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • 市場課題
  • COVID-19の影響分析
  • ポーターのファイブフォース分析
  • PESTLE分析

第5章 世界のゲノム編集技術市場分析:タイプ別

  • 主な調査結果
  • タイプセグメントの成長見通し
  • CRISPR
  • TALEN
  • ZFN
  • アンチセンス
  • その他
  • 世界のゲノム編集技術の市場規模の推定と予測:タイプ別

第6章 世界のゲノム編集技術市場分析:用途別

  • 主な調査結果
  • 用途セグメントの成長見通し
  • 細胞株エンジニアリング
  • 遺伝子エンジニアリング
  • 診断用途
  • 創薬・創薬
  • その他
  • 世界のゲノム編集技術の市場規模の推定と予測:用途別

第7章 世界のゲノム編集技術市場分析:エンドユーザー別

  • 主な調査結果
  • エンドユーザーセグメントの成長見通し
  • バイオテクノロジー企業
  • 製薬企業
  • 学術機関・政府機関
  • その他
  • 世界のゲノム編集技術の市場規模の推定と予測:エンドユーザー別

第8章 北米のゲノム編集技術市場分析

第9章 欧州のゲノム編集技術市場分析

第10章 アジア太平洋のゲノム編集技術市場分析

第11章 ラテンアメリカのゲノム編集技術市場分析

第12章 中東・アフリカのゲノム編集技術市場分析

第13章 競合情勢

  • 企業ランキング
  • 主要なビジネス戦略分析
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • GenScript
  • Sangamo Therapeutics Inc.
  • Lonza
  • Editas Medicine
  • CRISPR Therapeutics AG
  • Agilent Technologies Inc.
  • Precision Biosciences
  • Tecan Life Sciences

第14章 結論・提言

図表

List of Tables

  • Table 1 Global Genome Editing Technologies Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
  • Table 2 Approved Cellular and Gene Therapy Products, 2022
  • Table 3 Global Genome editing technologies Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): "V" Shaped Recovery Scenario
  • Table 4 Global Genome editing technologies Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): "U" Shaped Recovery Scenario
  • Table 5 Global Genome editing technologies Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): "W" Shaped Recovery Scenario
  • Table 6 Global Genome editing technologies Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR(%)): "L" Shaped Recovery Scenario
  • Table 7 CRISPR Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 8 CRISPR Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 9 TALEN Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 10 ZFN Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
  • Table 11 Antisense Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 12 Others Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 13 Global Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 14 Thermo Fischer Cell Line Services
  • Table 15 CRISPR Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 16 Genetic Engineering Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 17 Diagnostic applications Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 18 RNA Drugs Approvals
  • Table 19 Drugs Approvals
  • Table 20 Notable Clinical Trials Results
  • Table 21 Drug Discovery & Development Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 22 Others Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 23 Global Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 24 Biotechnology Companies Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 25 Pharmaceutical Companies Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 26 Academic & Government Research Institutes Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 27 Others Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 28 Global Genome editing technologies Market Forecast by End-User, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 29 North America Genome editing technologies Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 30 North America Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 31 North America Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 32 North America Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 33 U.S. Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 34 US Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 35 US Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 36 US Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 37 Canada Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 38 Canada Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 39 Canada Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 40 Canada Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 41 Europe Genome editing technologies Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 42 Europe Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 43 Europe Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 44 Europe Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 45 Germany Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 46 Germany Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 47 Germany Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 48 Germany Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 49 UK Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 50 UK Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 51 UK Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 52 UK Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 53 France Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 54 France Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 55 France Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 56 France Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 57 Italy Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 58 Italy Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 59 Italy Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 60 Italy Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 61 Spain Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 62 Spain Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 63 Spain Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 64 Spain Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 65 Russia Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 66 Russia Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 67 Russia Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 68 Russia Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 69 Rest of Europe Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 70 Rest of Europe Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 71 Rest of Europe Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 72 Rest of Europe Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 73 Asia Pacific Genome editing technologies Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 74 Asia Pacific Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 75 Asia Pacific Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 76 Asia Pacific Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 77 China Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 78 China Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 79 China Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 80 China Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 81 Japan Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 82 Japan Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 83 Japan Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 84 Japan Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 85 India Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 86 India Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 87 India Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 88 India Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 89 Philippines Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 90 Philippines Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 91 Philippines Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 92 Philippines Genome editing technologies Market Forecast by End-users, 2022- 2032 (US$ million, AGR%, CAGR %)
  • Table 93 South Korea Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 94 South Korea Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 95 South Korea Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 96 South Korea Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 97 Rest of Asia Pacific Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 98 Rest of Asia Pacific Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 99 Rest of Asia Pacific Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 100 Rest of Asia Pacific Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 101 Latin America Genome editing technologies Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 102 Latin America Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 103 Latin America Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 104 Latin America Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 105 Brazil Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 106 Brazil Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 107 Brazil Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 108 Brazil Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 109 Argentina Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 110 Argentina Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 111 Argentina Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 112 Argentina Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 113 Rest of Latin America Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 114 Rest of Latin America Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 115 Rest of Latin America Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 116 Rest of Latin America Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 117 Middle East & Africa Genome editing technologies Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 118 Middle East & Africa Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 119 Middle East & Africa Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 120 Middle East & Africa Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
  • Table 121 GCC Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 122 GCC Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 123 GCC Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 124 GCC Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 125 South Africa Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 126 South Africa Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 127 South Africa Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 128 South Africa Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR %)
  • Table 129 Rest of Middle East & Africa Genome editing technologies Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
  • Table 130 Rest of Middle East & Africa Genome editing technologies Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
  • Table 131 Rest of Middle East & Africa Genome editing technologies Market Forecast by Application, 2022-2032 (US$ million, AGR%, CAGR%)
  • Table 132 Rest of Middle East & Africa Genome editing technologies Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
  • Table 133 Top 10 Ranking of Key Vendors in Genome Editing Technologies Market, 2021
  • Table 134 Key Business Strategies Adopted by Key Players in Global Genome editing technologies Market
  • Table 135 Thermo Fisher Scientific Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 136 Thermo Fisher Scientific Inc.: Product Benchmarking
  • Table 137 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 138 Merck KGaA: Product Benchmarking
  • Table 139 GenScript: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 140 GenScript: Product Benchmarking
  • Table 141 Sangamo Therapeutics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 142 Sangamo Therapeutics Inc.: Product Benchmarking
  • Table 143 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 144 Lonza: Product Benchmarking
  • Table 145 Editas Medicine: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 146 Editas Medicine: Product Benchmarking
  • Table 147 CRISPR Therapeutics AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 148 CRISPR Therapeutics AG: Product Benchmarking
  • Table 149 Agilent Technologies Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 150 Agilent Technologies Inc.: Product Benchmarking
  • Table 151 Precision Biosciences: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 152 Precision Biosciences: Product Benchmarking
  • Table 153 Tecan Life Sciences: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 154 Tecan Life Sciences: Product Benchmarking

List of Figures

  • Figure 1 Global Genome editing technologies Market Segmentation
  • Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, & Region
  • Figure 3 Global Genome editing technologies Market Forecast by Region: Market Attractiveness Index
  • Figure 4 Global Genome editing technologies Market by Type: Market Attractiveness Index
  • Figure 5 Global Genome editing technologies Market by Application: Market Attractiveness Index
  • Figure 6 Global Genome editing technologies Market by End-users: Market Attractiveness Index
  • Figure 7 Global Precision Medicine Market: Market Dynamics
  • Figure 8 Global COVID Impact Analysis: Genome editing technologies Market Recovery Scenarios
  • Figure 9 Global Genome editing technologies Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): "V" Shaped Recovery
  • Fig
目次
Product Code: PHA1182

The Global Genome Editing Technologies market is estimated to be valued at US$ 4,225.48 million in 2022. The market is projected to reach a market value of US$ 18,570.41 million by 2032. We predict strong revenue growth through to 2032.

The Genome Editing Technologies Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to understand the industry and its underlying dynamics better. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The rise in chronic illnesses and infectious diseases is a primary driver of the genome editing technologies market

Cancer is one of the world's leading health problems, affecting millions of people of all ages and genders and having a significant influence on the quality of life. The cancer incidence rate was 20 million new in 2020 and is expected to reach 30 million new cases per year by 2040. Genome editing technologies provide new opportunities in fundamental cancer research and diagnostics, with advantages such as simple design, rapid operation, low cost, and robust scaling. CRISPR/Cas is a rapidly evolving editing technique that is been applied to almost all genomic targets. Several genome editing techniques, including zinc finger endonuclease (ZFN), transcription activator-like effector nuclease (TALEN), and the clustered regularly interspaced short palindromic repeats/CRISPR associated nuclease (CRISPR/Cas) system, have been developed to provide efficient gene editing for the treatment of cancers, infectious diseases, and genetic disorders. Furthermore, CRISPR gene editing is becoming an increasingly significant technique in the field of infectious disease research.

CRISPR has the potential to treat a wide range of infectious diseases, including viruses, bacteria, and fungi. CRISPR has a wide range of applications in the research of viral diseases and the creation of new therapies, and the discovery of RNA-targeting Cas nucleases has opened up new avenues for targeting RNA viruses, including SARS-CoV-2 vaccines.

Personalization of gene therapy faces a significant barrier in genome editing technologies

Personalization is the most significant barrier to autologous therapies since it introduces unpredictability into the process, both qualitatively and quantitatively (e.g., the number of cells harvested from each patient). It complicates scaling the procedure and necessitates the development of flexible cell culture platforms to accommodate the variety in the kind and number of cells taken from patients. It implies that several platforms must be run in parallel using a scale-out method rather than a scale-up approach. Some contract development and manufacturing organizations (CDMOs) have already penetrated this market to serve this need.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Genome Editing Technologies market evolving?
  • What is driving and restraining the Genome Editing Technologies market?
  • How will each Genome Editing Technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
  • How will the market shares for each Genome Editing Technologies submarket develop from 2022 to 2032?
  • What will be the main driver for the overall market from 2022 to 2032?
  • Will leading Genome Editing Technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the Genome Editing Technologies projects for these leading companies?
  • How will the industry evolve during the period between 2020 and 2032? What are the implications of Genome Editing Technologies projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialization to further scale the Genome Editing Technologies market?
  • Where is the Genome Editing Technologies market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Genome Editing Technologies market today, and over the next 10 years:

  • Our 416-page report provides 154 tables and 279 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Genome Editing Technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2032 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Genome Editing Technologies prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Type

  • CRISPR
  • TALEN
  • ZFN
  • Antisense
  • Others

Application

  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostic applications
  • Drug discovery & development
  • Others

End-user

  • Biotechnology companies
  • Pharmaceutical companies
  • Academic & Government Research Institutes
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America

  • U.S.
  • Canada
  • Mexico

Europe

  • Germany
  • Spain
  • United Kingdom
  • France
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

LAMEA

  • Brazil
  • Turkey
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Latin America

The report also includes profiles and for some of the leading companies in the Genome Editing Technologies Market, 2022 to 2032, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

  • Agilent Technologies Inc.
  • CRISPR Therapeutics AG
  • Editas Medicine
  • GenScript
  • Lonza
  • Merck KGaA
  • Precision Biosciences
  • Sangamo Therapeutics Inc.
  • Tecan Life Sciences
  • Thermo Fisher Scientific Inc.

Overall world revenue for Genome Editing Technologies Market, 2022 to 2032 in terms of value the market will surpass US$ 4,225.48 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Genome Editing Technologies Market, 2022 to 2032 report help you?

In summary, our 410+ page report provides you with the following knowledge:

  • Revenue forecasts to 2032 for Genome Editing Technologies Market, 2022 to 2032 Market, with forecasts market by techniques and company size, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2032 for four regional and 17 key national markets - See forecasts for the Genome Editing Technologies Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 12 of the major companies involved in the Genome Editing Technologies Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Genome Editing Technologies Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Genome editing technologies Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered By This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Premium Insights

  • 3.1 Geographical Snapshot: Global Genome editing technologies Market
  • 3.2 Type Segment: Market Attractiveness Index
  • 3.3 Application Segment: Market Attractiveness Index
  • 3.4 End-users Segment: Market Attractiveness Index

4 Market Overview

  • 4.1 Key Findings
  • 4.2 Market Dynamics
    • 4.2.1 Market Driving Factors
    • 4.2.2 Market Restraining Factors
    • 4.2.3 Market Opportunities
    • 4.2.4 Market Challenges
  • 4.3 COVID-19 Impact Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Supplier Power (Medium to High)
    • 4.4.2 Buyer Power (Low to Medium)
    • 4.4.3 Competitive Rivalry (Medium to High)
    • 4.4.4 Threat from Substitutes (Low to Medium)
    • 4.4.5 Threat of New Entrants (Low to Medium)
  • 4.5 PESTLE Analysis
    • 4.5.1 Political
    • 4.5.2 Economical
    • 4.5.3 Environment
    • 4.5.4 Social
    • 4.5.5 Technology
    • 4.5.6 Legal

5 Global Genome Editing Technologies Market Analysis by Type

  • 5.1 Key Findings
  • 5.2 Type Segment Growth Prospects
  • 5.3 CRISPR
    • 5.3.1 Key Statistics for Leading CRISPR-Based Therapeutic Companies and Agents in Clinical Development, 2021
    • 5.3.2 Top 15 CRISPR Start-up Companies Shaping Biotech and Medicine's Future, 2022
    • 5.3.3 CRISPR-Cas CLINICAL TRIALS, 2022
    • 5.3.4 Emerging CRISPR Therapies, 2022
    • 5.3.5 CRISPR Market Forecast by Region, 2022-2032 (US$ Bn)
    • 5.3.6 CRISPR Market Share by Region, 2022-2032 (%)
    • 5.3.7 Key CRISPR-Based Findings
  • 5.4 TALEN
    • 5.4.1 TALEN Clinical Trials
    • 5.4.2 TALEN Market Forecast by Region, 2022-2032 (US$ Bn)
    • 5.4.3 TALEN Market Share by Region, 2022-2032 (%)
  • 5.5 ZFN
    • 5.5.1 ZINC FINGER NUCLEASE (ZFN) Clinical Trials, 2022
    • 5.5.2 ZFN Market Forecast by Region, 2022-2032 (US$ Bn)
    • 5.5.3 ZFN Market Share by Region, 2022-2032 (%)
  • 5.6 Antisense
    • 5.6.1 Clinical development activities of antisense medicines
    • 5.6.2 Antisense Market Forecast by Region, 2022-2032 (US$ Bn)
    • 5.6.3 Antisense Market Share by Region, 2022-2032 (%)
  • 5.7 Others
    • 5.7.1 Others Market Forecast by Region, 2022-2032 (US$ Bn)
    • 5.7.2 Others Market Share by Region, 2022-2032 (%)
  • 5.8 Global Genome editing technologies Market Size Estimation and Forecast by Type

6 Global Genome editing technologies Market Analysis by Application

  • 6.1 Key Findings
  • 6.2 Application Segment Growth Prospects
  • 6.3 Cell Line Engineering
    • 6.3.1 Cell Line Engineering Market Forecast by Region, 2022-2032 (US$ Bn)
    • 6.3.2 Cell Line Engineering Market Share by Region, 2022-2032 (%)
  • 6.4 Genetic Engineering
    • 6.4.1 Genetic Engineering Market Forecast by Region, 2022-2032 (US$ Bn)
    • 6.4.2 Genetic Engineering Market Share by Region, 2022-2032 (%)
  • 6.5 Diagnostic applications
    • 6.5.1 Diagnostic applications Market Forecast by Region, 2022-2032 (US$ Bn)
    • 6.5.2 Diagnostic Applications Market Share by Region, 2022-2032 (%)
  • 6.6 Drug discovery & development
    • 6.6.1 RNA drugs approvals
    • 6.6.2 Notable drug approvals
    • 6.6.3 Notable clinical trial results (3Q21)
    • 6.6.4 Drug Discovery & Development Market Forecast by Region, 2022-2032 (US$ Bn)
    • 6.6.5 Drug Discovery & Development Applications Market Share by Region, 2022-2032 (%)
  • 6.7 Others
    • 6.7.1 Others Market Forecast by Region, 2022-2032 (US$ Bn)
    • 6.7.2 Other Applications Market Share by Region, 2022-2032 (%)
  • 6.8 Global Genome editing technologies Market Size Estimation and Forecast by Application

7 Global Genome editing technologies Market Analysis by End-user

  • 7.1 Key Findings
  • 7.2 End-user Segment Growth Prospects
  • 7.3 Biotechnology companies
    • 7.3.1 Biotechnology Companies Market Forecast by Region, 2022-2032 (US$ Bn)
    • 7.3.2 Biotechnology companies Market Share by Region, 2022-2032 (%)
  • 7.4 Pharmaceutical companies
    • 7.4.1 Pharmaceutical Companies Market Forecast by Region, 2022-2032 (US$ Bn)
    • 7.4.2 Pharmaceutical companies Market Share by Region, 2022-2032 (%)
  • 7.5 Academic & Government Research Institutes
    • 7.5.1 Academic & Government Research Institutes Market Forecast by Region, 2022-2032 (US$ Bn)
    • 7.5.2 Academic & Government Research Institutes Market Share by Region, 2022-2032 (%)
  • 7.6 Others
    • 7.6.1 Others Market Forecast by Region, 2022-2032 (US$ Bn)
    • 7.6.2 Others Market Share by Region, 2022-2032 (%)
  • 7.7 Global Genome editing technologies Market Size Estimation and Forecast by End-User

8 North America Genome editing technologies Market Analysis

  • 8.1 Key Findings
  • 8.2 North America Genome editing technologies Market Attractiveness Index
  • 8.3 North America Genome editing technologies Market by Country, 2022, 2027 & 2032 (US$ Mn)
  • 8.4 North America Genome Editing Technologies Market Size Estimation and Forecast by Country
  • 8.5 North America Genome editing technologies Market Size Estimation and Forecast by Type
  • 8.6 North America Genome editing technologies Market Size Estimation and Forecast by Application
  • 8.7 North America Genome editing technologies Market Size Estimation and Forecast by End-users
  • 8.8 U. S.
    • 8.8.1 U.S. Genome editing technologies Market by Type
    • 8.8.2 US Genome editing technologies Market Size Estimation and Forecast by Application
    • 8.8.3 US Genome editing technologies Market Size Estimation and Forecast by End-users
  • 8.9 Canada
    • 8.9.1 Canada Genome editing technologies Market by Type
    • 8.9.2 Canada Genome editing technologies Market Size Estimation and Forecast by Application
    • 8.9.3 Canada Genome editing technologies Market Size Estimation and Forecast by End-users

9 Europe Genome editing technologies Market Analysis

  • 9.1 Key Findings
  • 9.2 Europe Genome editing technologies Market Attractiveness Index
  • 9.3 Europe Genome editing technologies Market by Country, 2022, 2027 & 2032 (US$ Mn)
  • 9.4 Europe Genome editing technologies Market Size Estimation and Forecast by Country
  • 9.5 Europe Genome editing technologies Market Size Estimation and Forecast by Type
  • 9.6 Europe Genome editing technologies Market Size Estimation and Forecast by Application
  • 9.7 Europe Genome editing technologies Market Size Estimation and Forecast by End-users
  • 9.8 Germany
    • 9.8.1 Germany Genome editing technologies Market by Type
    • 9.8.2 Germany Genome editing technologies Market Size Estimation and Forecast by Application
    • 9.8.3 Germany Genome editing technologies Market Size Estimation and Forecast by End-users
  • 9.9 UK
    • 9.9.1 UK Genome editing technologies Market by Type
    • 9.9.2 UK Genome editing technologies Market Size Estimation and Forecast by Application
    • 9.9.3 UK Genome editing technologies Market Size Estimation and Forecast by End-users
  • 9.10 France
    • 9.10.1 France Genome editing technologies Market by Type
    • 9.10.2 France Genome editing technologies Market Size Estimation and Forecast by Application
    • 9.10.3 France Genome editing technologies Market Size Estimation and Forecast by End-users
  • 9.11 Italy
    • 9.11.1 Italy Genome editing technologies Market by Type
    • 9.11.2 Italy Genome editing technologies Market Size Estimation and Forecast by Application
    • 9.11.3 Italy Genome editing technologies Market Size Estimation and Forecast by End-users
  • 9.12 Spain
    • 9.12.1 Spain Genome editing technologies Market by Type
    • 9.12.2 Spain Genome editing technologies Market Size Estimation and Forecast by Application
    • 9.12.3 Spain Genome editing technologies Market Size Estimation and Forecast by End-users
  • 9.13 Russia
    • 9.13.1 Russia Genome editing technologies Market by Type
    • 9.13.2 Russia Genome editing technologies Market Size Estimation and Forecast by Application
    • 9.13.3 Russia Genome editing technologies Market Size Estimation and Forecast by End-users
  • 9.14 Rest of Europe
    • 9.14.1 Rest of Europe Genome editing technologies Market by Type
    • 9.14.2 Rest of Europe Genome editing technologies Market Size Estimation and Forecast by Application
    • 9.14.3 Rest of Europe Genome editing technologies Market Size Estimation and Forecast by End-users

10 Asia Pacific Genome editing technologies Market Analysis

  • 10.1 Key Findings
  • 10.2 Asia Pacific Genome editing technologies Market Attractiveness Index
  • 10.3 Asia Pacific Genome editing technologies Market by Country, 2022, 2027 & 2032 (US$ Mn)
  • 10.4 Asia Pacific Genome editing technologies Market Size Estimation and Forecast by Country
  • 10.5 Asia Pacific Genome editing technologies Market Size Estimation and Forecast by Type
  • 10.6 Asia Pacific Genome editing technologies Market Size Estimation and Forecast by Application
  • 10.7 Asia Pacific Genome editing technologies Market Size Estimation and Forecast by End-users
  • 10.8 China
    • 10.8.1 China Genome editing technologies Market by Type
    • 10.8.2 China Genome editing technologies Market Size Estimation and Forecast by Application
    • 10.8.3 China Genome editing technologies Market Size Estimation and Forecast by End-users
  • 10.9 Japan
    • 10.9.1 Japan Genome editing technologies Market by Type
    • 10.9.2 Japan Genome editing technologies Market Size Estimation and Forecast by Application
    • 10.9.3 Japan Genome editing technologies Market Size Estimation and Forecast by End-users
  • 10.10 India
    • 10.10.1 India Genome editing technologies Market by Type
    • 10.10.2 India Genome editing technologies Market Size Estimation and Forecast by Application
    • 10.10.3 India Genome editing technologies Market Size Estimation and Forecast by End-users
  • 10.11 Philippines
    • 10.11.1 Philippines Genome editing technologies Market by Type
    • 10.11.2 Philippines Genome editing technologies Market Size Estimation and Forecast by Application
    • 10.11.3 Philippines Genome editing technologies Market Size Estimation and Forecast by End-users
  • 10.12 South Korea
    • 10.12.1 South Korea Genome editing technologies Market by Type
    • 10.12.2 South Korea Genome editing technologies Market Size Estimation and Forecast by Application
    • 10.12.3 South Korea Genome editing technologies Market Size Estimation and Forecast by End-users
  • 10.13 Rest of Asia Pacific
    • 10.13.1 Rest of Asia Pacific Genome editing technologies Market by Type
    • 10.13.2 Rest of Asia Pacific Genome editing technologies Market Size Estimation and Forecast by Application
    • 10.13.3 Rest of Asia Pacific Genome editing technologies Market Size Estimation and Forecast by End-users

11 Latin America Genome editing technologies Market Analysis

  • 11.1 Key Findings
  • 11.2 Latin America Genome editing technologies Market Attractiveness Index
  • 11.3 Latin America Genome editing technologies Market by Country, 2022, 2027 & 2032 (US$ bn)
  • 11.4 Latin America Genome editing technologies Market Size Estimation and Forecast by Country
  • 11.5 Latin America Genome editing technologies Market Size Estimation and Forecast by Type
  • 11.6 Latin America Genome editing technologies Market Size Estimation and Forecast by Application
  • 11.7 Latin America Genome editing technologies Market Size Estimation and Forecast by End-users
  • 11.8 Brazil
    • 11.8.1 Brazil Genome editing technologies Market by Type
    • 11.8.2 Brazil Genome editing technologies Market Size Estimation and Forecast by Application
    • 11.8.3 Brazil Genome editing technologies Market Size Estimation and Forecast by End-users
  • 11.9 Argentina
    • 11.9.1 Argentina Genome editing technologies Market by Type
    • 11.9.2 Argentina Genome editing technologies Market Size Estimation and Forecast by End-users
  • 11.10 Rest of Latin America
    • 11.10.1 Rest of Latin America Genome editing technologies Market by Type
    • 11.10.2 Rest of Latin America Genome editing technologies Market Size Estimation and Forecast by Application
    • 11.10.3 Rest of Latin America Genome editing technologies Market Size Estimation and Forecast by End-users

12 Middle East & Africa Genome editing technologies Market Analysis

  • 12.1 Key Findings
  • 12.2 Middle East & Africa Genome editing technologies Market Attractiveness Index
  • 12.3 Middle East & Africa Genome editing technologies Market by Country, 2022, 2027 & 2032 (US$ bn)
  • 12.4 Middle East & Africa Genome editing technologies Market Size Estimation and Forecast by Country
  • 12.5 Middle East & Africa Genome editing technologies Market Size Estimation and Forecast by Type
  • 12.6 Middle East & Africa Genome editing technologies Market Size Estimation and Forecast by Application
  • 12.7 Middle East & Africa Genome editing technologies Market Size Estimation and Forecast by End-users
  • 12.8 GCC
    • 12.8.1 GCC Genome editing technologies Market by Type
    • 12.8.2 GCC Genome editing technologies Market Size Estimation and Forecast by Application
    • 12.8.3 GCC Genome editing technologies Market Size Estimation and Forecast by End-users
  • 12.9 South Africa
    • 12.9.1 South Africa Genome editing technologies Market by Type
    • 12.9.2 South Africa Genome editing technologies Market Size Estimation and Forecast by Application
    • 12.9.3 South Africa Genome editing technologies Market Size Estimation and Forecast by End-users
  • 12.10 Rest of Middle East & Africa
    • 12.10.1 Rest of Middle East & Africa Genome editing technologies Market by Type
    • 12.10.2 Rest of Middle East & Africa Genome editing technologies Market Size Estimation and Forecast by Application
    • 12.10.3 Rest of Middle East & Africa Genome editing technologies Market Size Estimation and Forecast by End-users

13 Competitive Landscape

  • 13.1 Company Ranking
  • 13.2 Key Business Strategy Analysis
  • 13.3 Thermo Fisher Scientific Inc
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Financial Analysis
    • 13.3.4 Product Benchmarking
    • 13.3.5 Strategic Outlook
  • 13.4 Merck KGaA
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Financial Analysis
    • 13.4.4 Product Benchmarking
    • 13.4.5 Strategic Outlook
  • 13.5 GenScript
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Financial Analysis
    • 13.5.4 Product Benchmarking
    • 13.5.5 Strategic Outlook
  • 13.6 Sangamo Therapeutics Inc.
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Financial Analysis
    • 13.6.4 Product Benchmarking
    • 13.6.5 Strategic Outlook
  • 13.7 Lonza
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Financial Analysis
    • 13.7.4 Product Benchmarking
    • 13.7.5 Strategic Outlook
  • 13.8 Editas Medicine
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Financial Analysis
    • 13.8.4 Product Benchmarking
    • 13.8.5 Strategic Outlook
  • 13.9 CRISPR Therapeutics AG
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Financial Analysis
    • 13.9.4 Product Benchmarking
    • 13.9.5 Strategic Outlook
  • 13.10 Agilent Technologies Inc.
    • 13.10.1 Company Snapshot
    • 13.10.2 Company Overview
    • 13.10.3 Financial Analysis
    • 13.10.4 Product Benchmarking
    • 13.10.5 Strategic Outlook
  • 13.11 Precision Biosciences
    • 13.11.1 Company Snapshot
    • 13.11.2 Company Overview
    • 13.11.3 Financial Analysis
    • 13.11.4 Product Benchmarking
    • 13.11.5 Strategic Outlook
  • 13.12 Tecan Life Sciences
    • 13.12.1 Company Snapshot
    • 13.12.2 Company Overview
    • 13.12.3 Financial Analysis
    • 13.12.4 Product Benchmarking
    • 13.12.5 Strategic Outlook

14 Conclusion and Recommendations

  • 14.1 Concluding Remarks from
  • 14.2 Recommendations for Market Players